A ‘Miracle’ HIV Drug May Not Reach the Women Who Need It Most
Listen to the Story - A podcast by Bloomberg
Categories:
Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the twice-yearly injection into doubt.See omnystudio.com/listener for privacy information.
